TR201921851A2 - 2-[[BENZYLIDINE]HYDRAZINYLIDINE]-5-OXOIMIDAZOLIDIN-4-YL SYNTHESIS OF ACETIC ACID DERIVATIVE COMPOUNDS - Google Patents

2-[[BENZYLIDINE]HYDRAZINYLIDINE]-5-OXOIMIDAZOLIDIN-4-YL SYNTHESIS OF ACETIC ACID DERIVATIVE COMPOUNDS

Info

Publication number
TR201921851A2
TR201921851A2 TR2019/21851A TR201921851A TR201921851A2 TR 201921851 A2 TR201921851 A2 TR 201921851A2 TR 2019/21851 A TR2019/21851 A TR 2019/21851A TR 201921851 A TR201921851 A TR 201921851A TR 201921851 A2 TR201921851 A2 TR 201921851A2
Authority
TR
Turkey
Prior art keywords
hydrazinylidine
oxoimidazolidin
synthesis
acetic acid
benzylidine
Prior art date
Application number
TR2019/21851A
Other languages
Turkish (tr)
Inventor
Saripinar Emi̇n
Kekeçmuhammed Hüseyi̇n
Acer Yeli̇z
Original Assignee
T C Erciyes Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T C Erciyes Ueniversitesi filed Critical T C Erciyes Ueniversitesi
Priority to TR2019/21851A priority Critical patent/TR201921851A2/en
Publication of TR201921851A2 publication Critical patent/TR201921851A2/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, heterohalkalı 2-[[benzilidine]hydrazinylidine-5-oksoimidazolidin-4-yl asetik asit türevlerinin sentezi ve kanser, bakteriyel veya şeker hastalığının tedavisinde kullanılabileceği ihtimali ile ilgilidir.The invention relates to the synthesis of heterocyclic 2-[[benzilidine]hydrazinylidine-5-oxoimidazolidin-4-yl acetic acid derivatives and the possibility of their use in the treatment of cancer, bacterial or diabetes mellitus.

TR2019/21851A 2019-12-26 2019-12-26 2-[[BENZYLIDINE]HYDRAZINYLIDINE]-5-OXOIMIDAZOLIDIN-4-YL SYNTHESIS OF ACETIC ACID DERIVATIVE COMPOUNDS TR201921851A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2019/21851A TR201921851A2 (en) 2019-12-26 2019-12-26 2-[[BENZYLIDINE]HYDRAZINYLIDINE]-5-OXOIMIDAZOLIDIN-4-YL SYNTHESIS OF ACETIC ACID DERIVATIVE COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/21851A TR201921851A2 (en) 2019-12-26 2019-12-26 2-[[BENZYLIDINE]HYDRAZINYLIDINE]-5-OXOIMIDAZOLIDIN-4-YL SYNTHESIS OF ACETIC ACID DERIVATIVE COMPOUNDS

Publications (1)

Publication Number Publication Date
TR201921851A2 true TR201921851A2 (en) 2021-07-26

Family

ID=83366299

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/21851A TR201921851A2 (en) 2019-12-26 2019-12-26 2-[[BENZYLIDINE]HYDRAZINYLIDINE]-5-OXOIMIDAZOLIDIN-4-YL SYNTHESIS OF ACETIC ACID DERIVATIVE COMPOUNDS

Country Status (1)

Country Link
TR (1) TR201921851A2 (en)

Similar Documents

Publication Publication Date Title
EA200800555A1 (en) DERIVATIVES OF XANTHINE AS SELECTIVE AGONISTS HM74A
TW201000488A (en) Heterocyclic derivatives
EA201000091A1 (en) DERIVATIVES OF MORFOLINOPYRIMIDINE USED IN DISEASES ASSOCIATED WITH mTOR KINASE AND / OR PI3K
CY1114617T1 (en) AMINOTETRA DYPROPHANY AS SUSPENDED PIPELINE DIPLOMATIC-IV FOR ORDER OR PREVENTION OF DIABETES
NZ590754A (en) Pyridin-4-yl substituted 2-carboxamide pyrrolidine-amide urea derivatives and their use in the treatment of phosphatidylinositol 3-kinase mediated diseases
ME01285A (en) Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
CY1115952T1 (en) PYRIDOLINE PYRASOLINE PRODUCERS AS NADRI OXIDATION INHIBITIONS
EA201100971A1 (en) DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION
EA201001368A1 (en) HETEROCYCLIC UREA DERIVATIVES AND METHODS OF THEIR APPLICATION-211
MA32723B1 (en) Anilino-pyrimidine derivatives substituted with sulfoximine marked as CDK inhibitors, their preparation and use as drugs
ATE442142T1 (en) FREDERICAMYCIN DERIVATIVES AS DRUGS FOR TUMOR TREATMENT
EA201000098A1 (en) HINAZOLINAMIDE DERIVATIVES
EA201391236A1 (en) NEW CYCLIC DERIVATIVES OF AZABENZIMIDAZOLE, USED AS ANTI-DIABETIC AGENTS
NO20060091L (en) Use of Condensed Heterocycles as SCCE Inhibitors for the Treatment of Skin Problems or Cancer
CO6300954A2 (en) DERIVATIVES OF TIENOPIRIDINONES AS PROTEIN QUINASA ACTIVATORS ACTIVATED BY AMPK
DK2324008T3 (en) Diarylpyrazole as protein kinase inhibitors
BRPI0716598A2 (en) N-BIARILA (HETERO) ARYLPHONAMIDE DERIVATIVES USEFUL IN TREATMENT OF DISEASES MEASURED BY LYMPHOCYTE INTERACTIONS
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
TW200635878A (en) Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use
PE20141855A1 (en) DISUSTITUTED BENZOTHENYL-PYRROLOTRIAZINES AND THEIR USES
EA200802223A1 (en) 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS
EA201100007A1 (en) QUINOXALINDION DERIVATIVES
EA200801996A1 (en) 2-SUBSTITUTED DERIVATIVES OF 4-BENZIL-PHTHALASINONES AS HISTAMINE H1-AND H3-ANTAGONISTS
MA32544B1 (en) Derivatives of pyridino pyridinone - their preparation and application in treatment
ATE524181T1 (en) USE OF 1,4-BIS(3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES